Zobrazeno 1 - 10
of 29
pro vyhledávání: '"MESH: Viral Matrix Proteins"'
Autor:
Paul F. Horwood, Andrew R. Greenhill, Aeron C. Hurt, Sokhoun Yann, San Sorn, Songha Tok, Davun Holl, Annika Suttie, Srey Viseth Horm, Yi-Mo Deng, Erik A. Karlsson, Philippe Dussart, Sothyra Tum, Ian G. Barr
Publikováno v:
Virology
Virology, Elsevier, 2018, 523, pp.22-26. ⟨10.1016/j.virol.2018.07.028⟩
Virology, Elsevier, 2018, 523, pp.22-26. ⟨10.1016/j.virol.2018.07.028⟩
International audience; Live bird market surveillance for avian influenza viruses in Cambodia in 2015 has led to the detection of two 7:1 reassortant influenza A(H5N1) clade 2.3.2.1c viruses. These reassortant strains, designated A/duck/Cambodia/ Z56
Autor:
Tianhou Wang, Licheng Zhou, Xu-Guang Xi, Hongwei Xu, Yongjin Wang, Xiaoming Wang, Huiling Shi, Tetsuya Toyoda, Hong Yao
Publikováno v:
Biochemical and Biophysical Research Communications
Biochemical and Biophysical Research Communications, Elsevier, 2009, 385 (1), pp.118-122. ⟨10.1016/j.bbrc.2009.04.129⟩
Biochemical and Biophysical Research Communications, Elsevier, 2009, 385 (1), pp.118-122. ⟨10.1016/j.bbrc.2009.04.129⟩
International audience; The ectodomain of influenza A virus M2 protein (M2e) is composed of 24 amino acids and induces antibodies with inhibitory effect against a broad spectrum of influenza A subtypes in vitro and in vivo. Although relatively conser
Autor:
Andrea Maisner, Gary P. Kobinger, Stephan Becker, Erik Dietzel, Anja Heiner, Larissa Kolesnikova, Veronika von Messling, Bevan Sawatsky, Michael Weis
Publikováno v:
Journal of Virology
Journal of Virology, American Society for Microbiology, 2016, 90 (5), pp.2514-22. ⟨10.1128/JVI.02920-15⟩
Journal of Virology, American Society for Microbiology, 2016, 90 (5), pp.2514-22. ⟨10.1128/JVI.02920-15⟩
Nipah virus (NiV) causes fatal encephalitic infections in humans. To characterize the role of the matrix (M) protein in the viral life cycle, we generated a reverse genetics system based on NiV strain Malaysia. Using an enhanced green fluorescent pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::265d75529bb8d048e2828aa2e1b7a51b
https://hal-riip.archives-ouvertes.fr/pasteur-01351097
https://hal-riip.archives-ouvertes.fr/pasteur-01351097
Autor:
Ronan N. Rouxel, Cecile Grange, Veronika von Messling, Jean Daniel Doucet, Marie Andrée Forget, Réjean Lapointe, Nathalie Arbour
Publikováno v:
Journal of General Virology
Journal of General Virology, Microbiology Society, 2011, 92 (Pt 5), pp.1162-71. ⟨10.1099/vir.0.029777-0⟩
Journal of General Virology, Microbiology Society, 2011, 92 (Pt 5), pp.1162-71. ⟨10.1099/vir.0.029777-0⟩
Current influenza vaccines containing primarily hypervariable haemagglutinin and neuraminidase proteins must be prepared against frequent new antigenic variants. Therefore, there is an ongoing effort to develop influenza vaccines that also elicit str
Publikováno v:
Journal of Virology
Journal of Virology, 2010, 84 (19), pp.9897-906. ⟨10.1128/JVI.00761-10⟩
Journal of Virology, American Society for Microbiology, 2010, 84 (19), pp.9897-906. ⟨10.1128/JVI.00761-10⟩
Journal of Virology, 2010, 84 (19), pp.9897-906. ⟨10.1128/JVI.00761-10⟩
Journal of Virology, American Society for Microbiology, 2010, 84 (19), pp.9897-906. ⟨10.1128/JVI.00761-10⟩
The lyssavirus matrix (M) protein induces apoptosis. The regions of the M protein that are essential for triggering cell death pathways are not yet clearly defined. We therefore compared the M proteins from two viruses that have contrasting character
Autor:
Véronique Fafeur, Tan-Sothea Ouk, Claude Auriault, Eric Masy, Denis Tranchand-Bunel, Georg W. Bornkamm, Jean Coll, Eric Adriaenssens, Jean Feuillard, Christophe Le Clorennec, Alexandra Mougel, Evelyne Manet, Gautier Goormachtigh
Publikováno v:
J. Virol. 80, 7382-7393 (2006)
Journal of Virology
Journal of Virology, 2006, 80 (15), pp.7382-93. ⟨10.1128/JVI.02052-05⟩
Journal of Virology, American Society for Microbiology, 2006, 80 (15), pp.7382-93. ⟨10.1128/JVI.02052-05⟩
Journal of Virology
Journal of Virology, 2006, 80 (15), pp.7382-93. ⟨10.1128/JVI.02052-05⟩
Journal of Virology, American Society for Microbiology, 2006, 80 (15), pp.7382-93. ⟨10.1128/JVI.02052-05⟩
Epstein-Barr virus (EBV) is associated with several human malignancies where it expresses limited subsets of latent proteins. Of the latent proteins, latent membrane protein 1 (LMP1) is a potent transforming protein that constitutively induces multip
Autor:
Georg W. Bornkamm, Jean Feuillard, Ibtissam Youlyouz-Marfak, Christophe Le Clorennec, Eric Adriaenssens, Jean Coll
Publikováno v:
Blood
Blood, American Society of Hematology, 2006, 107 (5), pp.2070-8. ⟨10.1182/blood-2005-05-2053⟩
Blood, American Society of Hematology, 2006, 107 (5), pp.2070-8. ⟨10.1182/blood-2005-05-2053⟩
Epstein-Barr virus (EBV) induces CD95 expression and the CD95 gene (FAS) is regulated by NF-kappaB, STAT1, and/or p53. To understand the contribution of these factors in the regulation of CD95 by EBV in lymphoblastoid cell lines (LCLs), we cloned dom
Autor:
Georg W. Bornkamm, Ibtissam Youlyouz-Marfak, Olivier Schischmanoff, Imen Najjar, Christophe Le Clorennec, Jean Feuillard, Remi Fagard, Christelle Laguillier, Fanny Baran-Marszak, Martine Raphael, Martin Schlee
Publikováno v:
Journal of Virology
Journal of Virology, American Society for Microbiology, 2005, 79 (8), pp.4936-43. ⟨10.1128/JVI.79.8.4936-4943.2005⟩
Journal of Virology, American Society for Microbiology, 2005, 79 (8), pp.4936-43. ⟨10.1128/JVI.79.8.4936-4943.2005⟩
Constitutive activation of signal transducer and activator of transcription 1 (STAT1) is a distinctive feature of Epstein-Barr virus (EBV)-immortalized B cells (lymphoblastoid cell lines [LCLs]). The expression of STAT1 in these cells is modulated by
Autor:
Fabienne Meggetto, Alan Bénard, Nadine Cogne, Aurélie Chanut, Nathalie Faumont, Georges Delsol, Jean Feuillard
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2009, 94 (3), pp.355-63. ⟨10.3324/haematol.13269⟩
Haematologica, Ferrata Storti Foundation, 2009, 94 (3), pp.355-63. 〈10.3324/haematol.13269〉
Haematologica, Ferrata Storti Foundation, 2009, 94 (3), pp.355-63. ⟨10.3324/haematol.13269⟩
Haematologica, Ferrata Storti Foundation, 2009, 94 (3), pp.355-63. 〈10.3324/haematol.13269〉
International audience; BACKGROUND: In Epstein-Barr virus-associated Hodgkin's lymphomas, neoplastic Reed-Sternberg cells and surrounding non-tumor B-cells contain different variants of the LMP1-BNLF1 oncogene. In this study, we raised the question o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d63b85580e725e32a7e93f2e8be615
https://hal.archives-ouvertes.fr/hal-00397989
https://hal.archives-ouvertes.fr/hal-00397989
Publikováno v:
Virology Journal
Virology Journal, BioMed Central, 2014, 11, pp.94
Virology Journal, BioMed Central, 2014, 11, pp.94
Background Epstein-Barr virus (EBV) is associated with 20-40% of Hodgkin’s Lymphoma (HL) cases. EBV-encoded latent membrane protein 1 (LMP1) is a well-known oncogenic protein and two C-terminal deletion variants, del30-LMP1 and del69-LMP1, have bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f1711bca71e82bcb211c03702748ee
https://hal.univ-grenoble-alpes.fr/hal-01132354
https://hal.univ-grenoble-alpes.fr/hal-01132354